Reliability and Validity of the Glittre Activities of Daily Living Test in Multiple Sclerosis Patients
Launched by HACETTEPE UNIVERSITY · Nov 27, 2019
Trial Information
Current as of August 15, 2025
Completed
Keywords
ClinConnect Summary
Multiple Sclerosis (MS) is a chronic, inflammatory disease characterized by demyelination, myelin damage, axonal loss and gliosis in the Central Nervous System (CNS). MS symptoms vary according to the size of the lesion and its location in the CNS. Clinical symptoms are generally: spasticity, fatigue, muscle weakness, tremor, pain, sensory disturbances, bladder bowel problems, cognitive disorders, depression and sleep disorders. With the progression of the disease, the performance in daily living activities gradually decreases, affecting the quality of life negatively. Maintaining aerobic c...
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • Between 18-65 years
- • Relapsing Remitting Multiple Sclerosis (RRMS) type MS disease.
- • Extended Disability Status Scale (EDSS) score of maximum 4.5
- • No attacks during the last 3 months
- • The medication has not been changed in the last 6 months.
- • Getting more than 24 points from the Standardized Mini Mental Test.
- • Exclusion Criteria
- • Having had any musculoskeletal surgery.
- • Using a walking aid or orthosis.
- • Having a neurological disease other than MS.
- • Having orthopedic or rheumatological problems that will affect function.
- • Having a peripheral vestibular problem.
- • Having a cardiovascular and pulmonary disease.
About Hacettepe University
Hacettepe University is a leading research institution in Turkey, renowned for its commitment to advancing medical science and healthcare through innovative clinical research. With a strong emphasis on interdisciplinary collaboration, the university supports a wide range of clinical trials aimed at improving patient outcomes and developing new therapeutic approaches. Hacettepe University is dedicated to maintaining the highest ethical standards and regulatory compliance in its research endeavors, fostering an environment that promotes scientific excellence and contributes to the global body of medical knowledge.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Ankara, , Turkey
Ankara, Sıhhiye/Ankara, Turkey
Patients applied
Trial Officials
Nezire KÖSE, Prof.
Principal Investigator
Hacettepe University
Rana KARABUDAK, Prof.
Study Chair
Hacettepe University
Meryem A TUNCER, Prof.
Study Chair
Haceetepe University
Kadriye ARMUTLU, Prof.
Principal Investigator
Hacettepe University
Yeliz SALCI, Asts. Prof.
Principal Investigator
Hacettepe University
Jale KARAKAYA, Assoc. Prof.
Principal Investigator
Hacettepe University
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported
Similar Trials